Aberrant outputs of glutamatergic neurons in deep cerebellar nuclei mediate dystonic movements

While the cerebellum is increasingly recognized as a critical node in the pathophysiology of dystonia, the specific contributions of distinct neuronal populations within the deep cerebellar nuclei (DCN)—glutamatergic, glycinergic, and GABAergic—remain poorly understood. This study investigates which of these DCN populations drive dystonic behaviors in Prrt2-mutant mice, a model of paroxysmal kinesigenic dyskinesia.

The researchers employed a multi-faceted approach, combining fiber photometry to monitor real-time calcium activity in specific DCN neuronal populations during induced dystonia, optogenetic stimulation to test the sufficiency of these populations to trigger dystonia in wild-type mice, and Cre-dependent caspase-mediated ablation to test the necessity of these neurons in preventing dystonia in mutant models.

The study reveals that all three major DCN neuronal populations exhibit sustained calcium elevation during dystonic episodes in Prrt2-mutant mice. However, optogenetic activation experiments demonstrated that only the glutamatergic DCN neurons are sufficient to induce dystonia-like behaviors in normal mice. Furthermore, selective ablation of these glutamatergic neurons significantly reduced both the severity and frequency of dystonia attacks in both Prrt2-mutant and kainic acid-induced dystonia models. The authors propose that the aberrant activity of these glutamatergic neurons is likely triggered by the disinhibition resulting from the suppression of Purkinje cell inhibitory output during cerebellar spreading depolarization.

These findings identify DCN glutamatergic neurons as a central, causal hub for cerebellar-originated dystonia. By pinpointing a specific neuronal population that is both necessary and sufficient for the manifestation of dystonic movements, this research provides a clear target for future therapeutic interventions, such as cell-type-specific neuromodulation or targeted pharmacological strategies, potentially offering more precise treatments than current broad-spectrum deep brain stimulation.